Microvascular networks support metabolic activity and define microenvironmental conditions within tissues in health and pathology. Recapitulation of functional microvascular structures in vitro could provide a platform for the study of complex vascular phenomena, including angiogenesis and thrombosis. We have engineered living microvascular networks in three-dimensional tissue scaffolds and demonstrated their biofunctionality in vitro. We describe the lithographic technique used to form endothelialized microfluidic vessels within a native collagen matrix; we characterize the morphology, mass transfer processes, and long-term stability of the endothelium; we elucidate the angiogenic activities of the endothelia and differential interactions with perivascular cells seeded in the collagen bulk; and we demonstrate the nonthrombotic nature of the vascular endothelium and its transition to a prothrombotic state during an inflammatory response. The success of these microvascular networks in recapitulating these phenomena points to the broad potential of this platform for the study of cardiovascular biology and pathophysiology.
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tissue engineering | regenerative medicine | microfluidics | cancer | blood T he microvasculature is an extensive organ that mediates the interaction between blood and tissues. It defines the biological and physical characteristics of the microenvironment within tissues and plays a role in the initiation and progression of many pathologies, including cancer (1) and cardiovascular diseases (2, 3) . Conventional planar cultures fail to recreate the in vivo physiology of the microvasculature with respect to three-dimensional (3D) geometry (lumens and axial branching points), and interactions of endothelium with perivascular cells, extracellular tissue and blood flow (4) . Studies of the microvasculature in vivo allow only limited control of physical, chemical, and biological parameters influencing the microvasculature and present challenges with respect to observation (5) . In vitro cultures that produce tubular vessels within 3D matrices will aid in elucidation of the roles of the microvasculature in health and disease. Important progress has been made toward this goal: Biologically derived or synthetic materials have been used to generate macrovessel tubes (6) and endothelialized microtubes (7); cellular self-assembly has been used to generate random microvasculature (8) ; microfabrication has been used to define complex geometries in hydrogels at the micro-scale (9) ; and distributions of cells and biochemical factors within 3D scaffolds (10) . Of particular note, the group of Tien has pioneered the use of collagen to template the growth of vascular endothelium (7, 11) and demonstrated appropriate permeability (7) , response to cyclic AMP (12) , and differential properties as a function of the luminal shear stress and composition of the medium (13) . Nonetheless, prior methodologies have been unable to produce endothelialized networks that can undergo substantial remodeling via angiogenesis; elucidate the roles of perivascular cells in modulating vascular morphology and permeability; control cellular, chemical, and physical stimuli at microscale levels to manipulate the interactions between different cell types and their matrices; and produce vessels with normal antithrombotic function when quiescent and prothrombotic behavior when exposed to inflammatory stimuli.
Here, we address these challenges by defining networks of endothelialized microchannels within matrices of type I collagen, a microfluidic vascular network (μVN). With long-term (one to two weeks) cultures of these μVNs, we demonstrate the emergence of appropriate endothelial morphology and barrier function (Fig. 1A, i) . We then proceed to investigate angiogenic remodeling (Fig. 1A , ii), interactions between endothelial cells (ECs) and perivascular cells (Fig. 1A, iii) , and interactions between blood components and endothelium with flow (Fig. 1A, iv) . These experiments indicate recapitulation of important characteristics of microvessels observed in vivo in both healthy and pathological scenarios and suggest important biophysical mechanisms by which geometry and luminal flow define function. We discuss the potential relevance of our system for modeling tumor progression, inflammation, thrombosis, and other pathologies.
Results
Engineering μVNs in Type I Collagen. We engineered μVNs by seeding human umbilical vein endothelial cells (HUVECs) into microfluidic circuits formed via soft lithography in a type I collagen gel. Native, type I collagen at 6-10 mg∕mL is of an appropriate stiffness to allow high reproducibility of vessel microstructure and also enables remodeling through degradation and deposition of extracellular matrix. The lithographic process enables the formation of endothelium along the microfluidic channels and the incorporation of living cells within the bulk collagen (Fig. 1B) . The key steps in the process are definition of a microstructured silicone stamp as a master on which to mold collagen with microstructure; injection and gelation in situ of collagen with or without perivascular cells in plexiglass jigs (Fig. 1B and Fig. S1 ); and sealing together two collagen layers to form the enclosed fluidic structure by applying pressure within the final plexiglass device. The enclosed microstructure has an inlet and an outlet that enable the seeding of ECs and perfusion of the vessels with medium during culture (Fig. S1 ). ECs were cultured alone or with perivascular cells within the bulk collagen for up to two weeks with gravity-driven flow (SI Methods). Fig. 1C presents the morphology of a μVN formed by culturing ECs alone. The vessels were fixed and stained after two weeks of culture in growth medium (SI Methods). CD31 (Fig. 1C) and VE-cadherin (Fig. S2) were both expressed in regions of EC-EC contact; this expression and localization indicates the maintenance of the endothelial phenotype and the formation of intercellular junctions between ECs (14). These proteins, which define the restrictive barrier function of the endothelium in vivo (15) , were expressed throughout the whole network (Fig. 1C, i) , with no detectable differences at corners (Fig. 1C , ii) or bifurcations (Fig. 1C, iii) . Over the first 3 d in culture, the cross-sectional area of the microvessel expanded and changed profile from the original square cross-section defined lithographically (100 μm × 100 μm) toward an elliptical cross-section with larger dimension (150 μm × 120 μm). We observed no significant difference in the average cell size relative to that of 2D cultures (approximately 3 × 10 3 μm 2 per cell) (16) . This evolution indicates that the matrix (6-10 mg∕mL collagen with modulus of 200-500 Pa) (16) possesses the appropriate stiffness and the capacity for chemical remodeling by the ECs during spreading and proliferation. The ECs in μVNs exhibit a cobble-stone pattern with no net alignment. This venule-like morphology (17) may be maintained by the low flow shear stress (18) applied (0-10 dyne cm −2 with time average of 0.1 dyne cm −2 ). Ultrastructural analysis of the endothelium reveals extensive intracellular junctions (Fig. 1D ), including focal adherens junctions (Fig. 1D, i) , overlapping junctions (Fig. 1D , ii), and complex junctions (Fig. 1D, iii) . The appearance of these intercellular junctions and of pinocytotic vesicles (Fig. S2) indicates that the major systems for transport of molecules across the endothelium were intact, as expected in arterioles and capillaries (19) . The absence of intraluminal projections and the normal architecture of organelles indicate that the endohelium was quiescent, as one would expect in the absence of inflammation (20) . The endothelium throughout the μVNs presented a barrier to the transfer of solutes from the lumen into the matrix. As seen qualitatively in Fig. 1E , little permeation of a macromolecule (70 kDa FITC-Dextran) occurred over intervals of a few minutes; this behavior strongly contrasts that seen in the absence of endothelium (Fig. S3) Three-dimensional system have been developed to study sprouting angiogenesis in vitro, for example, endothelial sprouting from a planar endothelium into bulk collagen gel (24) , lateral endothelial sprouting into a collagen gel isolated between two microfluidic channels formed in PDMS silicone (25) , and 3D endothelial sprouting from microbead supports in a bulk gel (26) . None of these systems allows for the initiation of angiogenesis from native-like vessels with luminal flow and simultaneous control of the chemical and cellular microenvironment of the endothelium. We have exploited the versatility of μVNs to investigate the angiogenic response of an endothelium with and without local interactions with perivascular cells. To begin, we applied vasculogenic medium exogenously through μVNs with perfusion to mimic the proangiogenic environment found in the vicinity of ischemic tissue or solid tumors (24, 27) . After a week of exposure, μVNs presented the following properties ( Fig. 2A ): CD31 staining at regions of cell-cell contact was less organized (Fig. 2A, i) ; endothelial cells sprouted into the collagen matrix with lumens (Fig. S4A) ; and solute dyes leaked from the vicinity of the sprouts ( Fig. 2A, ii) . The average length of endothelial sprouts was 75.4 AE 22.4 μm with an areal density of 41.8 AE 3.1 mm −2 (n ¼ 4). This length was greater than that observed in a 2D sprouting assay with HUVECs in a monolayer on 10 mg∕mL collagen gels at day 14, but the invasion density was similar (invasion depth ¼ 38.0 AE 9.9 μm and invasion density ¼ 38.8 AE 14.9 mm −2 ) (16). Due to the increased permeability at the projections, the spatially averaged permeability was nearly one order of magnitude greater than that of μVNs cultured in regular growth medium (Fig. 2D) . Solute extravasations in regions of endothelial sprouting have been observed in vivo in the presence of strong proangiogenic signals, such as in tumor neovasculature (28) .
Interactions between ECs and perivascular cells define the structural and functional properties of microvessels (29) . When we seeded human brain vascular pericytes (HBVPCs), expressing both desmin and α-smooth muscle actin (α-SMA) in the bulk of the collagen gels, we observed two distinct behaviors. In half of the cases (Fig. 2B , n ¼ 3), we observed endothelial sprouting into the collagen matrix. Long sprouts, with lumens, grew into the collagen by day 14 (Fig. 2B , i. Average sprouting length of 174.3 AE 6.6 μm and density of 15.8 AE 1.2 mm −2 ). Brain pericytes are known to secrete both VEGF and FGF, which may have driven this sprouting, even in the absence of exogenous GFs (30) . Interestingly, these sprouts displayed good barrier properties (Fig. 2B , ii): The permeability of the vessels (Fig. 2D ) was similar to that of the EC-only case with growth medium and significantly lower than that obtained with exogenous growth factors. Pericytes associated sparsely with the endothelium (Figs. 2 B and S4B) and expressed both α-SMA (Fig. S4B ) and desmin (Fig. S4 D and E) .
In the other half of the experiments (Fig. 2C , n ¼ 3), we observed retraction of the endothelium from the walls of the microchannels (although the lumens remained open) and a complete absence of sprouts to day 14 ( Fig. 2C, i) . These retracted vessels were leakier (Fig. 2C , ii), with permeabilities similar to that of the EC-only vessels treated with exogenous GFs (Fig. 2D ). These vessels showed significantly higher coverage by pericytes than those observed in the other half of the experiments (Fig. 2D) , with the associating pericytes strongly expressing α-SMA (Fig. S4C ) (and weakly expressing desmin) (Fig. S4 F and G) .
The potential origins of the two distinct outcomes (sprouting and retracted) include variations in the percentage of the initial population of pericytes of a certain character (the seeding population is mixed, and one type of pericytes may express more contractile proteins in the retracted cases, for example), difference in the initial density of ECs (200 AE 100 cells∕mm 2 ), or in the structure of the collagen in which the channels were formed (e.g., variation of fiber architectures with mechanical forces, temperature and pH during gelation) (31) . In support of the first possibility, we note that experiments with purified populations of smooth muscle cells (human umbilical arterial smooth muscle cells) consistently (n ¼ 6) showed local retraction of the endothelium, luminal constriction, and the absence of sprouting (Fig. S5) .
For both outcomes, ultrastructural analysis ( Fig. S4 H and I) showed that the PCs were located between the collagen matrix and the ECs. In regions of close apposition of the two cell types, the ECs were polarized, with their focal adhesions anchored toward the perivascular cells. A basal lamina formed between the two cell types; this basal lamina was not detected around the vessels in areas devoid of adjacent pericytes.
When μVNs produced by coculture of ECs and HBVPCs (n ¼ 4) were perfused with vasculogenic media, we observed sprouting with no retraction (Fig. S4 J-L) . The sprouts were significantly longer and less frequent than for either the EC-only case with exogenous GFs or the EC-pericytes case without GFs (average length of 228.5 AE 35.9 μm and density of 7.2 AE 1.1 mm −2 ); the vessel permeability was intermediate between these two other cases (Fig. 2D ). These observations suggest that pericytes modulate the response of the μVNs to proangiogenic signals. The consistently low coverage of the vessels by pericytes and the lack of a retracted state suggest that the presence of proangiogenic factors suppressed recruitment of pericytes toward the microvessels; this behavior is consistent with the observation in vivo that VEGF is a negative regulator for perivascular recruitment (32).
Blood-Endothelium Interactions. In healthy scenarios, the endothelium provides a nonadhesive and antithrombotic interface for the transport of blood through the vessel whereas during inflammation, the endothelium promotes the formation of the thrombi via local expression and secretion of adhesive proteins (33) . The interaction of blood with endothelium has been studied extensively in vitro in planar formats that lack appropriate vessel geometries or a 3D matrix (34, 35) . We examined the interaction of whole blood and the endothelium in μVNs in a quiescent state (after 7 to 14 d in our standard microfluidic culture; see Methods and SI Methods) and a stimulated state induced by brief exposure to phorbol-12-myristate-13-acetate (PMA). Upon perfusion of the μVNs with whole human blood (citrate-stabilized with labeled platelets), we observed dramatically different behaviors in the two situations (Fig. 3 A-C) . In untreated μVNs, the vast majority of platelets flowed past the endothelial surface without adhering (Fig. 3A , i, and Movie S1). A small portion of platelets adhered reversibly and rolled along the endothelial surfaces. Localized, firm adhesion of platelets occurred only at some EC-EC junctions and at sites of defect in the endothelium (Fig. S6 A and B) , as has been reported in vivo at sites of endothelial injury (36) and on exposed subendothelial matrix (37) . Neither the transient nor firm binding led to formation of aggregates larger than 10 μm (Fig. S6 A and B) . In a collagen network with no endothelium, platelets immediately adhered and aggregated on the exposed collagen (Movie S2).
In stimulated vessels, large aggregates of platelets formed immediately on the endothelial surface (Fig. 3A , ii, and Movie S3). In the first minutes of perfusion, these aggregates proceeded to grow to fill a substantial fraction of the lumen and then were shed into the flowing blood (Fig. 3B) , possibly as a result of the rise in shear stress associated with the local decrease of lumen diameter during the formation of the thrombus (38) . Platelets continued to accumulate over time on the vessel wall (Fig. 3 B and C) . After 1 h of perfusion with blood, leukocytes were observed to attach on the luminal side of vessel walls and to begin migrating through the endothelium into the collagen matrix; some of the thrombi became stable (Fig. 3D and Fig. S6 C and D) .
To elucidate the mechanism of thrombosis in the stimulated vessels, we perfused μVNs with FITC-conjugated antibodies against von Willebrand factor (VWF). VWF is a protein that can be released from endothelial Weibel-Palade bodies (WPBs) and assemble into fibers on the endothelial surface upon endothelial activation (34) under flow. These fibers bind platelets; leukocytes and red blood cells also accumulate at these sites, possibly by binding the adherent platelets (Fig. S6G) (39) . PMA is a known secretagogue for VWF, working by activating protein kinase C. In unstimulated μVNs, we observed VWF in WPBs in the endothelial cytoplasm, but not on the endothelial surfaces (Fig. S7 A  and B) . In contrast, in the stimulated vessels, fibers of VWF with lengths up to 2 mm covered the surface of the vessels (Fig. 3E and  Fig. S7C ). These fibers bound to platelets, almost all irreversibly (Fig. 3F) , as shown previously on cultured endothelial cells (34) and in mice (40) . Electron micrographs illustrate the binding of platelets to the activated endothelium, with the density of bound platelets being the highest near bifurcations and vessel junctions (Figs. S6 E and F, and S7).
The importance of the 3D architecture of the μVNs manifests itself in the flow-driven pattern of VWF fibers and VWF-platelet strands observed around junctions and bifurcations in the network of vessels. Fibers that were anchored to the endothelium upstream of a bifurcation were convected off of the wall as the flow entered the junction, leading to the formation of 3D webs of fibers that traverse the lumen (Fig. 3G and Movie S3). This 3D network of VWF fibers increases the contact between the binding surfaces of the fibers and the components of the blood such that platelets are captured more efficiently and the flow is further perturbed (Fig. S7 D and E) . Such structures have not been reported in planar cultures in which the flow is uniaxial and parallel to the endothelium (35) , or in mouse models, where details of the progression of thrombosis have been difficult to resolve (40) .
Discussion
Our lithographic approach (Fig. 1B and Fig. S1 ) allows for the definition of endothelialized vessels with physiologically relevant geometries such as bifurcations and junctions within a matrix that is permissive of remodeling and 3D cell culture. Our functional studies indicate the usefulness of μVNs for the study of angiogenesis (Fig. 2) in healthy (Fig. 2B) and pathological ( Fig. 2A) scenarios, and thrombosis (Fig. 3 ) under quiescent and inflammatory conditions. Future work with μVNs could benefit from the use of alternative microfabrication techniques such as 3D printing (41) to extend the geometrical complexity of the networks.
The versatility of the μVN platform, with respect to its structure, cellular composition, and in situ control of the endothelial microenvironment, opens opportunities to address biophysical and biological questions that are difficult to access either in vivo or in conventional, planar cultures in vitro. These include the effects of geometry (42), hydrodynamic stresses, and transport processes (13, 43) on the stability of vessels, the progression of angiogenesis, and the interactions of the vessel with blood cells; and the roles of vascular cells from different organs in defining physiological and pathological states specific to those organs (for example, properties of the blood-brain barrier) (44) ; and the abnormal angiogenic and inflammatory profiles of solid tumors (45) and diabetic tissues (46) .
As our platform matures, we anticipate that μVNs can be used to test drugs and drug-delivery strategies that target microvascular function (for example, angiogenesis (47) and hypertension) (48) or blood-endothelium interactions (for example, sickle cell disease (49) and thrombotic thrombocytopenic purpura) (50) . Scaffolds with μVNs could also provide a starting point for the growth of vascularized tissues in vitro for applications in regenerative medicine (51) .
Methods
The microvessel networks were fabricated within native, type I collagen by molding microstructures in collagen gels with injection molding techniques (9) . Human umbilical vein endothelial cells (HUVECs) were seeded and cultured on the walls of the microchannels created in the collagen to form an endothelialized lumen. Human brain vascular pericytes (HBVPCs) or human umbilical arterial smooth muscle cells (HUASMCs) were embedded in collagen bulk for the study of interactions between endothelium and perivascular cells. The microvessel networks were cultured with gravitydriven flow of endothelial growth media for 7 to 14 d. The angiogenesis experiments were conducted with proangiogenic media containing exogenous vascular endothelial cell growth factor (VEGF), basic fibroblast growth factor (bFGF), and phorbol ester (PMA). The experiments of blood-endothelium interactions were performed with reconstituted whole blood that was stabilized with 3.8% sodium citrate containing labeled platelets and leukocytes. Live imaging was performed for the permeability measurement with the perfusion of fluorescent dyes or the whole blood interactions with the microvessels. At the designated time points, the microvessel network was fixed and stained in situ with perfusion of fixatives and antibodies through the lumens, followed by the fluorescence confocal microscopy, scanning electron microscopy or transmission electron microscopy. Detailed methods are available in SI Methods.
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SI Methods
Collagen Gel Preparation. Type I collagen was extracted from rat tails under sterile conditions, lyophilized, and dissolved in 0.1% acetic acid following a standard protocol (1) . A stock solution of collagen was prepared at the concentration of 15 mg∕mL, which was further diluted and neutralized to 6 or 10 mg∕mL with buffer solutions [1x Medium 199 (M199, Lonza), 10x M199, and 1 mol l −1 NaOH] on ice prior to the microvessel fabrication. For the study of endothelial-perivascular interactions, appropriate volume of concentrated suspension of perivascular cells was mixed into the neutralized collagen solution on ice for the designated concentration of collagen gels and density of cells.
Microvessel Scaffold Fabrication. The microvessel networks were fabricated within type I collagen at the concentrations of either 6 mg∕mL (Fig. 3) or 10 mg∕mL (Figs. 1 and 2) , and housed between two plexiglass pieces, which were sealed with mechanical pressure (Fig. 1B and Fig. S1 ). Upon fabrication, both plexiglass pieces were first sterilized via exposure to oxygen plasma (Harrick, 100 W for 4 min) and coated with 1% (v∕v) polyethylenimine (PEI) and 0.1% (v∕v) glutaraldehyde to provide adhesion to the collagen gels. The top plexiglass (Fig. S1A, 6 ) contained a well (20 mm × 20 mm × 1 mm) to define the thickness, size, and shape of the top collagen scaffold. There were two injection ports on the plexiglass; one was for injecting the collagen gel and the other for air to evacuate from the closed mold during the injection. Two stainless steel dowel pins were inserted into the other two holes in the top plexiglass to define inlet and outlet of the microvessel networks. The top jig was assembled (Fig. S1A, 1) by making a sandwich with the PDMS stamp on the bottom (Fig. S1A, 4) , the aluminum piece in the middle for alignment (Fig. S1A, 5) , and the top plexiglass on the top. The neutralized collagen gel with or without cells was then injected into the assembled top jig through one of the injection ports with a 1-mL syringe. The bottom plexiglass (Fig. S1A, 7 ) contained a well (25 mm × 25 mm × 0.2 mm) to define the thin flat layer of the bottom collagen. Upon fabrication, the neutralized collagen gel was dispensed on the glass coverslip in the bottom plexiglass, followed by placing a flat slab of PDMS stamp on the top (Fig. S1A, 2) .
The collagen gel was allowed to cross-link for 30 min at 37°C and 5% CO 2 . The assembled top jig (Fig. S1A, 1) contained the collagen gel with microfluidic structure, which would become the top part of the microchannel networks, and the assembled bottom jig (Fig. S1A, 2) contained a thin layer of collagen that would be the bottom of the networks. The device was assembled by placing the top plexiglass containing collagen scaffold with the microfluidic structures on the bottom plexiglass containing the flat slab of collagen gel (Fig. 1B and Fig. S1A, 3 ) and sealed by mechanical pressure. A PDMS reservoir (approximately 6 mm thick) (Fig. S1A, 8) was placed on the top of the device to serve as extended reservoirs over the inlet and outlet. Culture medium was added to the reservoirs and the assembled device was incubated at 37°C and 5% CO 2 for 2 h to allow the medium to replace the PBS buffer that remained in the device from assembly before seeding cells.
Cell Seeding and Culture. Human umbilical vein endothelial cells (HUVECs) (Lonza), human brain vascular pericytes (HBVPCs) (ScienCell Research Laboratories), and human umbilical cord arterial smooth muscle cells (HUASMCs) (Lonza) at passage numbers 3 to 8 were used. HUVECs, HBVPCs, and HUASMCs were maintained in culture flasks with growth medium (GM), pericyte medium (PM), and smooth muscle cell growth media (SmGM) respectively, in 37°C incubators with 5% CO 2 and ambient oxygen. Two types of endothelial growth media were used with one containing base medium M199 with 2% fetal bovine serum (FBS), and the other with 16% FBS. No significant differences were observed in the morphology or behavior of endothelial cells with these two different media.
Prior to seeding in collagen microchannels, HUVECs were trypsinized from the culture flask and suspended in growth media with density of 4.5 × 10 6 cells mL −1 . The growth media was removed from the reservoirs in the device with gel loading pipette tips and 10 μL of cell suspension was added to one reservoir such that the suspension flowed into the channels. The cellseeded devices were then placed back into incubators to allow cell attachment on the inner walls of the microchannels for 20 min. The culture medium with or without vasculogenic growth factors was then placed in both reservoirs with initial height difference of around 6 mm and refreshed every 12 h. This unbalanced initial condition in the levels of medium equilibrated over a period of approximately 2 h. This procedure defined a decaying, unidirectional Poiseuille flow within the channels with an average shear stress of approximately 0.1 dyne cm −2 .
In microvessel scaffolds containing cocultures (ECs with either HBVPCs or HUASMCs), HBVPCs or HUASMCs were trypsinized from the culture flask and suspended in their media with density of 2.0 × 10 6 cells mL −1 . Appropriate volumes of this cell suspension were mixed well with neutralized collagen to achieve the targeted concentrations of perivascular cells (1.0 × 10 5 cells mL −1 ) and of collagen (6 or 10 mg∕mL). Growth media-type I (GM): M199 with 16% FBS, L-glutamine, penicillin/streptomycin (P/S), (Lonza) and endothelial cell growth supplement (ECGS, Millipore Co.).
Growth media-type II (GM) (single quote kits from Lonza): M199 with 2% FBS, 1% P/S, epidermal growth factors (EGF), bovine brain extract with heparin (BBE), hydrocortisone, ascorbic acid, gentamicin and amphotericin B.
Proangiogenic media (VM): GM with 50 ng mL −1 vascular endothelial cell growth factor (VEGF), 50 ng mL −1 basic fibroblast growth factor (bFGF), 50 ng mL −1 Phorbol-12-myristate-13-acetate (TPA, Millipore Co.), and 50 ng mL −1 L-ascorbic acid (Acros Organics).
Pericyte media (PM) for HBVPCs: basal pericyte medium with 2% FBS, 1% pericyte growth supplement (PGS), and 1% P/S. (ScienCell Research Laboratories).
Smooth muscle cell growth media (SmGM) for HUASMCs: smooth Muscle Cell Basal Medium with 5% FBS, insulin, hFGF-2, gentamicin, hEGF, and 1% P/S (Lonza).
Immunofluorecence Stainings. At the designated time point, the devices were fixed in situ with 3.7% formaldehyde, washed three times with PBS, and immunohistochemically stained for CD31, α-Smooth muscle actin, and desmin; all reagents were delivered through the microchannels. The devices were first incubated for 30 min in a blocking solution consisting of 2% bovine serum albumin and 0.5% Triton-X for membrane permeablization. The devices were then incubated with primary antibodies overnight and secondary antibodies for 2 h. CD31 immunohistochemistry was performed using a rabbit polyclonal antibody CD31/platelet endothelial cell adhesion molecule-1 (1∶50 dilution, Abcam). α-Smooth muscle actin immunohistochemistry was performed using a mouse monoclonal α-SMA (1∶100 dilution, Invitrogen Co.). Desmin immunohistochemistry was performed using a mouse monoclonal desmin (1∶100 dilution, Invitrogen Co.). In addition, nuclei were stained with DAPI (Invitrogen Co.) for both cell identification and counting.
Analysis of Microfluidic Vascular Networks (μVNs).
The immunofluorescence images of μVNs were taken in situ using a Zeiss 510 Meta or a Nikon A1R confocal microscope. Image stacks were accumulated with a z-step between each successful optical slice of approximately 2 μm. Cross sections and three-dimensional (3D) reconstructions were generated from z-stacks of images in ImageJ with orthogonal projection, z-projection and 3D viewer. The density and length of endothelial sprouts from the microvascular network were measured in z-stacks of confocal images. In addition, for the co-culture experiment, perivascular recruitment around the vessel was analyzed through the expression of α-SMA and desmin. A 20-μm-thick zone around the vessels was defined for quantification of coating ratio; the fraction of positive-stained perivascular cells was counted in ImageJ. With the original seeding density of ECs (200-400 cells mm −2 in the lumen) and perivascular cells (0.1 × 10 6 cells mL −1 in the collagen bulk), we estimated that the original cell ratio of perivascular cells around the vascular network (PC:EC) was 0.05∶1.
Ultrastructral Analysis. All reagents were purchased from Electron Microscopy Sciences. For scanning electron microscopy (SEM), μVNs were fixed, dehydrated, critical-point-dried, sputter-coated with platinum-palladium, and analyzed using a FEI Sirion scanning electron microscope with an accelerating voltage of 5 kV. For transmission electron microscopy, constructs were perfused with modified Karnovsky's fixative (2.5% glutaraldehyde, 4% paraformaldehyde, 0.02% picric acid in 0.1 M sodium cacodylate buffer, pH 7.3) overnight. Blocks (1 mm 3 ) were postfixed in 1% osmium tetroxide/1.5% potassium-ferricyanide, stained with 1.5% uranyl acetate, and dehydrated through graded ethanol series. After embedding in Spurr's resin, sections were cut at 55-60 nm thickness using a Diatome diamond knife on a Leica Ultracut S ultramicrotome. Sections were contrasted with lead citrate and viewed on a JEOL JEM 100 CX-II electron microscope operated at 80 kV. Images were recorded on Kodak 4489 Electron Image film and then digitized at 900 dpi for publication.
Live Imaging of Whole Blood Perfusion and VWF Secretion. Fresh blood was drawn into 3.8% (0.129 M) sodium citrate from consenting healthy donors under protocols approved by the Institutional Review Board of the University of Washington. The blood was then centrifuged at 120 g for 15 min to isolate the plateletrich plasma and buffy coat. Platelets in the plate-rich plasma were labeled with Percp-cy5.5 conjugated CD41a antibody (1 μg mL −1 ) for 20 min at room temperature, and leucocytes in the buffy coat were labeled with FITC-conjugated CD45 antibody. The labeled platelets and leukocytes were reconstituted with red blood cells at the original ratio into whole blood.
The whole blood perfusion experiments were carried out in the μVNs after culturing them in growth media for 7 to 14 days; no differences were detected in the behavior of the vessels within this time range. The growth medium in the endothelial lumens was first washed away with PBS, followed by the blood perfusion through the μVNs at shear stresses between 10 and 30 dyne cm −2 for 15 min to one hour. The vessels were monitored through bright field and fluorescence imaging using an inverted microscope (Olympus, IX81). The fluorescence arising from individual platelets and aggregates attached to the vessel wall was recorded with a digital camera (CoolSNAP-at 1-5 fps), and analyzed using SlideBook. Platelet adhesion was quantified using Matlab for control and stimulated vessels with four replicates at each condition. After each experiment, the microvessel network was washed with PBS immediately, then fixed and stained for an endothelial marker (CD31) for further imaging.
Studies of VWF secretion and the interactions of blood with stimulated μVNs were performed as follows: The μVNs were activated with PMA (50 ng mL −1 in growth media) for 20 min at 1 μL min −1 (shear stress approximately 1 dyne cm −2 ), then washed with PBS buffer before perfusion of a FITC-conjugated VWF antibody (Abcam-100 μg mL −1 in growth media), or whole blood with labeled platelets. Live imaging was performed through a fluorescence microscope, and 3D structures were imaged and obtained in situ through a confocal microscope.
Measurement of Endothelial Permeability. We measured the diffusivity of small and large molecules in the acellular collagen matrix by delivering solutions of fluorescein (Sigma-Aldrich -10 μmol L −1 in PBS) and 70 kDa FITC-Dextran (SigmaAldrich-10 μmol L −1 in PBS) into the scaffold via microchannels (flow rate of 10 μL min −1 ). As soon as the microchannels were filled, the delivery was stopped and fluorescence images were acquired sequentially for 3-30 min with an inverted microscope (Olympus, IX81) using a CCD camera (Hamamatsu, Orca-ER). The images were analyzed using Slidebook software (Olympus) to estimate the diffusivity of fluorescent molecules in the collagen gels, as described previously (2) .
To determine the permeability of the endothelium, transient delivery experiments were carried out in μVNs (Figs. 1E and 2 A-C and Fig. S4 ). Fluorescent solutions in PBS were delivered through the channels with live endothelium at a continuous flow rate of 2 μL min −1 . Fluorescence images were acquired sequentially and image analysis was carried out in MATLAB (The Mathworks) to estimate the permeability of the endotheliaum, K [cm s
−1 ] as a function of known parameters (intensity of fluorescent solution, i 0 , initial background intensity i initial , intensity at the interchannel center i c , diffusivity of solute in collagen, D collagen , interchannel distance δ, and time t) based on the model of mass transfer developed below. Average values for K were obtained from four K values derived in each fivechannel device, and three to six devices were used for each condition (Fig. S3 B and C) .
We present the analysis of data such as in Fig. 1E . Fig. S3 illustrates our analysis of the transient diffusion of a solute from microchannels into the bulk material. In our analysis, we make two assumptions: The fluorescence intensity is proportional to the concentration of the fluorescent solute; this assumption is good for low concentration ranges of fluorescence (3) (1-10 μM fluorescence labeled solutes were employed in this presentation); and the concentration within the solution in the microchannels remains constant with respect to both time and the axial position along the channels; these approximations are accurate because we maintained sufficiently high flow rate to ensure high Péclet number (Pe ∼ 10 5 ) within the flow and high Biot number (Bi ∼ 10 3 ) for mass transfer from the solution to the walls of the channel (2) . The uniformity along the axial direction allows for the study of temporal modulation of fluorescence intensity within the bulk materials in a spatially uniform manner.
We take the constant fluorescent intensity within the channel to be i 0 (Fig. S3B ) and the intensity profile within the interchannel space (i.e., collagen bulk) to be iðx; tÞ. The solutes have diffusivity in collagen (D collagen ½m 2 s −1 ), and permeability coefficient across the endothelium at the microchannel boundary (K [m s −1 ]). We nondimensionalize the parameters as follows: The axis orthogonal to five vertical channels, as shown in Fig. S3B is defined as X ¼ x∕ðδ∕2Þ, the fluorescence intensity defined as IðX; τÞ ¼ iðx;tÞ−i 0 i initial −i 0 , and the time is defined as τ ¼
(the Fourier modulus).
In the region of interchannel collagen bulk, the governing equations for concentration distribution of solutes in scaled form is
The initial condition on Eq. S1 is CðX; 0Þ ¼ 1. The boundary conditions on Eq. S1 are: No flux at the center of interchannel space (X ¼ 0), and continuity of flux at the boundaries with the microchannels (X ¼ 1):
where the Biot number is defined as
With these conditions, Eq. S1 has the following solution:
A n e −λ 2 n τ cosðλ n XÞ;
where λ n is given by
For τ > 0.2( i.e. t > 23 s for 332 kDa fluorescein or t > 5 min for 70 kDa FITC-Dextran), the above solution reduces to:
At the center of interchannel space, we can further simplify the solution to be:
Taking the logarithm of both sides of Eq. S6 and moving back to dimensional variables, we have:
Thus, a linear fit of ln
vs. t gives λ 1 and via Eq. S4, S5 and the definition of Bi (Eq. S3) we obtain the permeability of the μVNs:
Statistical Analysis. Independent or paired t tests were used to compare group means for data presented in Figs. 2D and 3C. A p value <0.05 was considered significant for all tests. Three to six independent experiments were performed for each condition tested unless otherwise stated. In all bar plots, the data is presented as mean AE standard error from three to six samples for each experimental condition. Fig. 1E . (Lower) Schematic diagram of the time evolution of mass transfer from solutions in a section of the microfluidic scaffold as solute passed from the microchannels (green) to the collagen bulk (gray) across an endothelial barrier. The parameters are as follows: i 0 is the fluorescence intensity in the channels; i initial is the initial fluorescence intensity as a function of x;i c is the intensity at the center (x ¼ 0); D collagen is the diffusivity in collagen for the fluorescent solute;K is the permeability coefficient of the endothelium covering the walls of the channels; and t is the time interval since perfusion with the fluorescent solutions was initiated. (C) Log-linear plot of the measured time evolution of the fluorescence intensity at the center of four interchannel spaces for two example microvessel networks, one cultured in growth media (GM, Fig. 1E ), shown as blue lines, and the other cultured with one week of proangiogenic media (VM, Fig. 2A ), shown as the red lines. Movie S1. (Fig. 3 A and B ) Whole blood perfusion (in 3.8% citrate) through a quiescent μVN. Green, CD41a.
Movie S1 (WMV)
Movie S2. Whole blood perfusion (in 3.8% citrate) through a collagen microchannel network. Green, CD41a.
Movie S2 (WMV)
